Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

We performed a case-control genome-wide association study (GWAS) to identify single nucleotide polymorphisms (SNPs) associated with musculoskeletal adverse events (MS-AEs) in women treated with aromatase inhibitors (AIs) for early breast cancer. A nested case-control design was used to select patien...

Ausführliche Beschreibung